CalciMedica, Inc. (CALC)
Largest Insider Buys in Sector
CALC Stock Price History Chart
CALC Stock Performance
About CalciMedica, Inc.
CalciMedica, Inc., a clinical-stage biotechnology company, focuses on developing therapies for life-threatening inflammatory diseases with unmet needs. Its proprietary technology targets the inhibition of calcium release-activated (CRAC) channels designs to modulate the immune response and protect against tissue cell injury in life-threatening inflammatory diseases. Its lead product candidate is Auxora, a proprietary intravenous-formulated CRAC channel inhibitor for the treatment of acute pancreatitis, asparaginase-associated acute …
Insider Activity of CalciMedica, Inc.
Over the last 12 months, insiders at CalciMedica, Inc. have bought $6.73M and sold $0 worth of CalciMedica, Inc. stock.
On average, over the past 5 years, insiders at CalciMedica, Inc. have bought $3.37M and sold $0 worth of stock each year.
Highest buying activity among insiders over the last 12 months: MIDDLETON FRED A () — $14.66M. Sanderling Venture Partners VI LP (10 percent owner) — $5.03M. WILSON ROBERT N (director) — $2.43M.
The last purchase of 4,800 shares for transaction amount of $12,720 was made by MIDDLETON FRED A () on 2024‑12‑06.
List of Insider Buy and Sell Transactions, CalciMedica, Inc.
| 2024-12-06 | 4,800 0.033% | $2.65 | $12,720 | -3.50% | ||||
| 2024-11-01 | 10 percent owner | 87,744 0.7074% | $3.75 | $329,040 | -3.70% | |||
| 2024-11-01 | 107,744 0.8687% | $3.75 | $404,040 | -3.70% | ||||
| 2024-11-01 | director | 53,333 0.43% | $3.75 | $199,999 | -3.70% | |||
| 2024-11-01 | CHIEF BUSINESS OFFICER | 53,333 0.43% | $3.75 | $199,999 | -3.70% | |||
| 2024-11-01 | CHIEF EXECUTIVE OFFICER | 20,000 0.1612% | $3.75 | $75,000 | -3.70% | |||
| 2024-08-27 | CHIEF EXECUTIVE OFFICER | 1,000 0.009% | $4.19 | $4,190 | -6.53% | |||
| 2024-08-23 | director | 54,000 0.4318% | $3.72 | $200,826 | -1.62% | |||
| 2024-08-23 | CHIEF BUSINESS OFFICER | 5,000 0.0384% | $3.57 | $17,867 | -1.62% | |||
| 2024-08-21 | CHIEF BUSINESS OFFICER | 5,000 0.0434% | $4.04 | $20,200 | +1.41% | |||
| 2024-06-28 | director | 51,278 0.3881% | $3.52 | $180,499 | +3.03% | |||
| 2024-06-27 | director | 8,443 0.0587% | $3.23 | $27,305 | +29.37% | |||
| 2024-06-27 | CHIEF BUSINESS OFFICER | 5,000 0.0346% | $3.22 | $16,100 | +29.37% | |||
| 2024-04-02 | CHIEF BUSINESS OFFICER | 3,254 0.0273% | $3.90 | $12,691 | +5.94% | |||
| 2024-04-01 | CHIEF BUSINESS OFFICER | 746 0.0063% | $3.90 | $2,909 | +8.91% | |||
| 2024-01-23 | 10 percent owner | 679,384 5.4073% | $3.70 | $2.52M | -22.14% | |||
| 2024-01-23 | 679,384 5.4073% | $3.70 | $2.52M | -22.14% | ||||
| 2023-05-17 | CHIEF BUSINESS OFFICER | 3,000 0.0173% | $2.68 | $8,040 | +2.75% | |||
| 2010-03-19 | 10 percent owner | 56,010 0.1373% | $1.14 | $63,851 | ||||
| 2010-03-18 | 10 percent owner | 23,066 0.062% | $1.25 | $28,833 |